drug

IDE892

1 story · latest Aug 4, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by IDEAYA Biosciences

Timeline

IDEAYA reports Q2 2026 results, darovasertib trial hits primary endpoint

Aug 4Quarterly updatedarovasertib IDEAYA Biosciences

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.